Patel, D.M.; Mateen, R.; Qaddour, N.; Carrillo, A.; Verschraegen, C.; Yang, Y.; Li, Z.; Sundi, D.; Mortazavi, A.; Collier, K.A.
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines. Cancers 2024, 16, 335.
https://doi.org/10.3390/cancers16020335
AMA Style
Patel DM, Mateen R, Qaddour N, Carrillo A, Verschraegen C, Yang Y, Li Z, Sundi D, Mortazavi A, Collier KA.
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines. Cancers. 2024; 16(2):335.
https://doi.org/10.3390/cancers16020335
Chicago/Turabian Style
Patel, Dixita M., Ruba Mateen, Noor Qaddour, Alessandra Carrillo, Claire Verschraegen, Yuanquan Yang, Zihai Li, Debasish Sundi, Amir Mortazavi, and Katharine A. Collier.
2024. "A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines" Cancers 16, no. 2: 335.
https://doi.org/10.3390/cancers16020335
APA Style
Patel, D. M., Mateen, R., Qaddour, N., Carrillo, A., Verschraegen, C., Yang, Y., Li, Z., Sundi, D., Mortazavi, A., & Collier, K. A.
(2024). A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines. Cancers, 16(2), 335.
https://doi.org/10.3390/cancers16020335
